Fidelity Investments’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
Fidelity Investments's IBB Position: Q1 2026 in Review
Fidelity Investments increased its iShares Biotechnology ETF (IBB) stake by 15% in Q1 2026, buying an estimated $415K and bringing the position to 18,435 shares worth $3.11M. The position accounts for ﹤0.01% of the portfolio, ranked #2481.
Fidelity Investments first reported a position in IBB in Q2 2013 and has held it in 52 quarters since. The position peaked at $42.4M in Q4 2013. 919 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- Fidelity Investments held 18,435 shares of iShares Biotechnology ETF worth $3.11M as of Q1 2026.
- Fidelity Investments bought 2,424 iShares Biotechnology ETF shares in Q1 2026, an estimated $415K.
- iShares Biotechnology ETF made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #2481 holding.
- Fidelity Investments first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 52 quarters since.
- Fidelity Investments's iShares Biotechnology ETF position peaked at $42.4M in Q4 2013.
- 919 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.